ORIGINAL ARTICLE
Functional expression of voltage-gated calcium channels in human melanoma
Article first published online: 2 FEB 2012
DOI: 10.1111/j.1755-148X.2012.00978.x
© 2012 John Wiley & Sons A/S
Additional Information
How to Cite
Das, A., Pushparaj, C., Bahí, N., Sorolla, A., Herreros, J., Pamplona, R., Vilella, R., Matias-Guiu, X., Martí, R. M. and Cantí, C. (2012), Functional expression of voltage-gated calcium channels in human melanoma. Pigment Cell & Melanoma Research, 25: 200–212. doi: 10.1111/j.1755-148X.2012.00978.x
Publication History
- Issue published online: 22 FEB 2012
- Article first published online: 2 FEB 2012
- Accepted manuscript online: 19 JAN 2012 08:35PM EST
- PUBLICATION DATA Received 5 May 2011, revised and accepted for publication 16 January 2012, published online 19 January 2012
CORRIGENDUM: Corrigendum
Vol. 25, Issue 4, 537, Article first published online: 19 JUN 2012
Keywords:
- melanoma;
- voltage-gated calcium channels;
- PCR;
- calcium imaging;
- viability;
- cell cycle;
- pharmacology;
- siRNA
Summary
The expression of voltage-gated calcium channels (VGCCs) has not been reported previously in melanoma cells in spite of increasing evidence of a role of VGCCs in tumorigenesis and tumour progression. To address this issue we have performed an extensive RT-PCR analysis of VGCC expression in human melanocytes and a range of melanoma cell lines and biopsies. In addition, we have tested the functional expression of these channels using Ca2+ imaging techniques and examined their relevance for the viability and proliferation of the melanoma cells. Our results show that control melanocytes and melanoma cells express channel isoforms belonging to the Cav1 and Cav2 gene families. Importantly, the expression of low voltage-activated Cav3 (T-type) channels is restricted to melanoma. We have confirmed the function of T-type channels as mediators of constitutive Ca2+ influx in melanoma cells. Finally, pharmacological and gene silencing approaches demonstrate a role for T-type channels in melanoma viability and proliferation. These results encourage the analysis of T-type VGCCs as targets for therapeutic intervention in melanoma tumorigenesis and/or tumour progression.

1755-148X/asset/olbannercenter.gif?v=1&s=72f30e3842b97b67d7bc25d75c3ceea43fce9409)
